2011 Saw the Start of Your Mandate of President of EAHM. How was Your First Year in Charge and What did You Accomplish? As I have been active member of the association (Board and Executive Committee) for a long time now there is a certain continuity within the Presidency. The main activities of my Presidency focus on the implementation of the results...
READ MOREThe rapid growth of pharmaceutical expenditure driven by changing demographics, strict clinical targets, rising patient expectations and the continued launch of new expensive drugs has become a contentious issue in the healthcare sector. New expensive drugs include new biological drugs marketed at considerably higher costs than previous standards,...
READ MORETo acheive marketing approval, a molecule undergoes different development phases and a variety of studies need to be carried out. A new molecule typically involves preclinical testing in animals followed by clinical trials in humans, after which the application is submitted to regulatory agencies for review. In case of new delivery system,...
READ MOREAuthor Jill Davis, Interview by Lee Campbell Firstly What are Cytotoxic Drugs and What do We Use Them For? Cytotoxic drugs are drugs that kill cells. They are mainly used to treat cancer but can be used for other therapeutic indications e.g. rheumatoid arthritis, multiple sclerosis. Cytotoxic drugs mainly kill...
READ MOREIt is globally recognised that the only way to effectively support continuity of care is to implement an electronic health record (EHR) system on a large scale. The implementation of a national EHR is a high priority in the e-health strategies of most countries, regardless of whether they are first world or low- and middle-income countries. In...
READ MOREIT @ Networking Awards 2012 - 2nd Place Introducing Innovation in Healthcare These advances in genomic medicine are only possible due to the equal progress in the information technology sector. The diagnostic opportunities also bring new challenges to medical centres regarding privacy in general and the necessary ICT infrastructure...
READ MOREIT @ Networking Awards 2012 - 3rd Place The LV Prasad Eye Institute (LVPEI) was established in 1986-87 at Hyderabad as a not-for-profit, nongovernment, public-spirited, comprehensive eye care institution. From its very beginning, it set forth as its core values the “Three E’s”: Equity, Efficiency and Excellence. Equity translates as treating...
READ MOREAll licensed drugs have trial evidence that they work within their licensed indications, otherwise they would not have been granted a marketing authorisation by bodies such as the European Medicines Agency. Nevertheless they do not necessarily have to work particularly well or sufficiently well to justify their cost compared with other available...
READ MOREChallenges, Plans and Solutions Norway faces the same dilemma of many western European countries, as the standard of living improves and people’s life expectancy increases, there are new challenges with an ageing population and a growing number of people with chronic diseases. An ageing society will be a challenge for the Norwegian healthcare...
READ MOREThe Radiological Society of North America (RSNA) released the first version of the RadLex Playbook (http://playbook.rsna.org) on November 1 during the recently past RSNA congress, and already this resource has found eager users in the radiologic community. The Playbook provides a standard, uniformly structured set of names for radiology procedures....
READ MORE